Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colloidal silver and topical antibiotics for chronic rhinosinusitis after sinus surgery
ACTRN12623000011684Phase 2Recruiting
- Sponsor
- Central Adelaide Local Health Network
- Start
- Feb 2023
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silver nanoparticles, mupirocin, tobramycin, ciprofloxacin, amoxicillin + clavulanate in chronic rhinosinusitis (CRS), sponsored by Central Adelaide Local Health Network. Started Feb 2023; status: recruiting.
02
Drugs
silver nanoparticlesmupirocintobramycinciprofloxacinamoxicillin + clavulanate
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on ACTRN12623000011684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000011684.